Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-845-579-5705

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

T: +1-347-918-3531

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Liquid Biopsy Market Outlook for 2023 to 2033

The global Liquid Biopsy Market share is estimated to clock a revenue of US$ 1,538.3 million in 2023. Our healthcare domain experts opine that liquid biopsy providers can expect a robust CAGR of 21.7% through 2033, with a forecast valuation of US$ 10,938.6 million by 2033.

Attribute Details
Liquid Biopsy Market Size, 2022 US$ 1,264.3 million
Liquid Biopsy Market Size, 2023 US$ 1,538.3 million
Liquid Biopsy Market Size, 2033 US$ 10,938.6 million
Value CAGR (2023 to 2033) 21.7%

Top Trends Impacting the Liquid Biopsy Market

  • WHO, in 2020, reported around 10 million cancer-related deaths. Such a staggering rise in the incidence rate of different cancers strongly emphasizes the demand for convenient and precision cancer diagnostic tests for early detection.
  • Governments of different economies with a rising cancer burden have pledged to support cancer research by offering sufficient funds for improved outcomes. For instance, according to the National Institute of Health (NIH), the National Cancer Institute was allocated US$ 119 million by the federal government in the United States in 2021.
  • Researchers are continuously making new advancements in the biomarkers to detect and evaluate cancer by utilizing liquid biopsy. For instance, the development of new biomarkers for early cancer detection and subsequent treatment response.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Historical Growth of the Liquid Biopsy Market Vs. Forecast Outlook

Attributes Details
Liquid Biopsy Market Size (2018) US$ 580.16 million
Liquid Biopsy Market Size (2022) US$ 1,264.3 million
Historical CAGR % (2018 to 2022) 21.5%

The liquid biopsy market registered a CAGR of 21.5% from 2018 to 2022. Over the forecast period, the growth rate is predicted to increase decimals, resulting in 21.7% through 2033. As cancer continues to affect many people, with the present figures predicted to escalate over the next decade, the demand for cancer detection tests like liquid biopsy is expected to have practical application, given that new and efficient technologies are being explored. Mentioned below are the few factors that are contributing to market growth:

  • Increasing government-led initiatives are predicted to motivate cancer specialists worldwide to set research goals in cancer treatments, focusing on convenience, affordability, and optimal patient care.
  • An upsurge in funding is anticipated to permit experts to create research alliances to facilitate improvements against several cancer outcomes.
  • Quick approvals for non-invasive cancer diagnosis tests by regulatory bodies like the United States Food and Drug Administration (FDA) are creating opportunities for key players.
Historical CAGR % (2018 to 2022) 21.5%
Forecast CAGR % (2023 to 2033) 21.7%

Comparative View of Adjacent Liquid Biopsy Markets

For a comparative view of liquid biopsy, the market is compared with the aspiration and biopsy needles market and injection pen market. The table below highlights factors that are impacting these markets. Based on the market figure, the injection pen market is expected to obtain US$ 43.4 billion by 2023 end, significantly greater than the other two markets. Concerning CAGR, the liquid biopsy market is expected to enjoy a robust growth rate over the next decade, expanding at a higher CAGR of 21.7%.

Liquid Biopsy Market:

Attributes Liquid Biopsy Market
CAGR (2023 to 2033) 21.7%
Market Value (2023) US$ 1,538.3 million
Growth Factor Rising cancer patients
Future Opportunities Increasing government-led initiatives
Market Trends Surging research and development to arrive at an improved version of liquid biopsy

Aspiration and Biopsy Needles Market:

Attributes Aspiration and Biopsy Needles Market
CAGR (2023 to 2033) 6.1%
Market Value (2023) US$ 777.29 million
Growth Factor Increasing check-up camps for cancer
Future Opportunities Improving healthcare infrastructure
Market Trends Surge in key players investing in emerging economies for lower overhead costs

Injection Pen Market:

Attributes Injection Pen Market
CAGR (2023 to 2033) 7%
Market Value (2023) US$ 43.4 billion
Growth Factor Rising prevalence of chronic diseases like diabetes
Future Opportunities Increasing accessibility of injection pens to all geographies and for people of all ages
Market Trends Improvements in injection pens, like precise dosage administration and improved memory span
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Category-wise Insights

CTC Holds the Leading Share in the Liquid Biopsy Market

Leading Biomarker Type CTC (Circulating Tumor Cells)
Market Share % (2023) 56.9

The CTC (Circulating Tumor Cells) is predicted to account for a market share of 56.9% in 2023. Key factors that are propelling the use of CTCs over other liquid biopsy approaches are as follows:

  • The cells in CTCs are intact, which makes them applicable to an extensive range of biomarkers like gene expression, protein expression, and DNA mutations.
  • Surging demand for biomarkers that help detect cancer at any stage of its development. Since CTCs can be isolated from cancer patients at any stage of their disease, they assist in detecting cancer at any stage.
  • An increase in healthcare professionals are deploying CTCs to check the effectiveness of cancer treatment. By examining CTCs over extended periods, doctors can find out the response of a patient’s cancer to treatment and bring modifications in the treatment course.
  • Improvements carried out in CTC detection technology are predicted to further fuel its preference among healthcare specialists in the future.

Blood Sample Type Holds an Unbeatable Market Share

Leading Sample Type Blood
Market Share % (2023) 93.4

Blood sample type makes up for 93.4% of the overall market. Since blood samples taken from different body parts or at different intervals are easy to compare, they find a high utilization rate among healthcare professionals. Blood samples can be collected from patients of any age group and any health condition, which boosts its accessibility among patients. Thus, doctors and patients alike are increasingly opting for blood samples.

Country-wise Insights

Key Players to Benefit from the New Advancements in Liquid Biopsy in the United Kingdom

Country The United Kingdom
Forecast CAGR % (2023 to 2033) 26.4%

The United Kingdom liquid biopsy market is predicted to expand at a remarkable CAGR of 26.4% through 2033. Over the forecast period, the following factors are predicted to propel such growth rate in the United Kingdom:

  • Favorable healthcare policies and increasing expenditure on the healthcare system are together, impelling a conducive environment for liquid biopsy key players.
  • Cancer patients are predicted to see a spike over the next decade. This is predicted to highlight the necessity for liquid biopsy to diagnose patients at the early stage.
  • The presence of world-renowned research institutes in the United Kingdom, like the National Institute of Medical Research and the University of Oxford, catalyzes new advancements in test and technology.

Favorable Regulatory Environment Attracting Key Players to China

Country China
Forecast CAGR % (2023 to 2033) 29.7%

At present, China leads in terms of the sales rate of liquid biopsy tests. According to recent market research by FMI analysts, the China liquid biopsy market is predicted to observe a sensational CAGR of 29.7% through 2033. The following factors give a comprehensive look into such growth opportunities for key players:

  • The boom in cancer diagnostics as the country inhabits a significant proportion of the population showing symptoms of developing cancer. Therefore, surging healthcare professionals are prescribing cancer diagnostics to determine further tests and procedures.
  • The regulatory environment in China is in favor of quicker product approvals, thus motivating key players in their endeavor for product advancement.
  • Experienced technicians in China are available at a lower expense, which also creates a supportive environment for the growth of the liquid biopsy market in China.
  • Rising medical tourism in China is another key aspect influencing sales of liquid biopsy.

High Cancer Rate in India Drawing Investments by Established Key Players

Country India
Forecast CAGR % (2023 to 2033) 24.4%

As per the recent market survey by FMI's analysts, the India liquid biopsy market is estimated to register an impressive CAGR of 24.4% through 2033. Given below are the leading factors backing the demand for liquid biopsy:

  • Surging government initiatives to elevate cancer awareness are promoting the use of liquid biopsy.
  • Rising investigations in product development for improved precision and efficiency are creating a positive outlook for the liquid biopsy market.
  • The increasing incidence rate of cancer among the population residing in India. For instance, the National Cancer Registry found out that cancer incidences are predicted to reach 735,575 in males and 806,218 in females in the year 2025. This is expected to press the country's need for technologically advanced liquid biopsy systems.
  • An increase in biotech companies, both budding and established, are concentrating on bringing efficiencies in early diagnosis and advancements in cancer patient care and treatment. Thus, enhancing the scope of the liquid biopsy market in India.

Advancements in the Personalized Healthcare Treatment in Japan Augmenting Liquid Biopsy Market

Japan is a substantial market in Asia Pacific for liquid biopsy. The following factors propelling the deployment of liquid biopsy in the country:

  • The increase in projects in Japan to realize personalized cancer treatment is enhancing the demand for liquid biopsies in the country. For instance, in June 2020, the National Cancer Center Hospital East announced that it is going to launch ‘CIRCULATE-Japan’ project to create personalized cancer treatment via a liquid biopsy to test circulating tumor DNA in the blood of patients who have to go through surgery for colorectal cancer.
  • Key players in the country are aiming to develop a solution to offer advanced personalized healthcare. In March 2021, Chugai obtained approval for the use of FoundationOne Liquid CDx Cancer Genomic Profile, which is a comprehensive genomic profiling test to detect solid tumors.

Key Players are Seizing the Business Opportunities Presented by Australia Healthcare Scene

Country Australia
Forecast CAGR % (2023 to 2033) 20.2%

The Australia liquid biopsy market is expected to register a CAGR of 20.2% through 2033. The following factors are predicted to fuel the market growth:

  • Increasing presence of biotechnology and medical device companies in the country.
  • Extensive deployment of advanced technology to effectively treat cancer patients, along with the rising incidences of cancer in Australia.
  • Surging innovations in liquid biopsy procedures and technologies are propelling the market scope of liquid biopsy.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Gain Insights into the Strategic Moves of Key Players

Market participants delivering liquid biopsy tests are planning on strategically collaborating with end users like diagnostic centers, hospitals, and cancer research institutes to invigorate their product offerings in the market.

Manufacturers are further predicted to enjoy proprietary benefits by coming into product development and industry research funding agreements, which assist in creating precision diagnosis methods for different types of cancers. On top of this, key players are gaining government approvals and patents for new technologies to maintain their competitive edge in the market.

New Developments Observed in the Liquid Biopsy Market

  • Biocept Inc., a prominent provider of molecular diagnostic services, in July 2021, obtained a South Korean patent for Primer-Switch technology. This technology finds mutations in circulating tumor DNA via real-time PCR and associated methods, which helps identify rare cancer biomarkers.
  • Janssen Global Services, LLC, in July 2021, gained FDA permission for DARZALEX FASPRO, along with dexamethasone and pomalidomide, for treating adult patients suffering from multiple myeloma. Thus strengthening the firm's product offerings.
  • Thermo Fisher Scientific Inc., in August 2022, introduced the first NGS-based tests to facilitate RNA and DNA input. The Ion Torrent Oncomine Myeloid MRD Assays (RUO) offer a complete and extremely sensitive myeloid measurable residual (MDR) assessment of bone marrow and blood samples.

Companies Operating in the Liquid Biopsy Market

  • BIOCEPT, INC.
  • Qiagen N.V.
  • Trovagene, Inc
  • Janssen Global Services, LLC
  • MDxHealth SA
  • Natera, Inc
  • F. Hoffmann-La Roche Ltd
  • Silicon Biosystems
  • Pathway Genomics Corporation
  • Sysmex Corporation
  • Others

Report Scope

Report Attribute Details
Growth Rate CAGR of 21.7% from 2023 to 2033
Expected Market Value (2023) US$ 1,538.3 million
Anticipated Forecast Value (2033) US$ 10,938.6 million
Base Year for Estimation 2022
Historical Data 2018 to 2022
Forecast Period 2023 to 2033
Quantitative Units Revenue in US$ million and CAGR from 2023 to 2033
Report Coverage Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis
Segments Covered
  • Biomarker Type
  • Sample Type
  • Application Type
  • Region
Regions Covered
  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific Excluding Japan
  • Japan
  • The Middle East and Africa
Key Countries Profiled
  • The United States
  • Canada
  • Mexico
  • Brazil
  • Germany
  • Italy
  • France
  • The United Kingdom
  • Spain
  • Russia
  • Poland
  • China
  • Japan
  • South Korea
  • India
  • ASEAN
  • Australia and New Zealand
  • GCC Countries
  • South Africa
Key Companies Profiled
  • BIOCEPT, INC.
  • Qiagen N.V.
  • Trovagene, Inc
  • Janssen Global Services, LLC
  • MDxHealth SA
  • Natera, Inc
  • F. Hoffmann-La Roche Ltd
  • Silicon Biosystems
  • Pathway Genomics Corporation
  • Sysmex Corporation
  • Others
Customization Available Upon Request

Key Segments Profiled in the Liquid Biopsy Industry Survey

By Biomarker Type:

  • CTCs (Circulating Tumour Cells)
  • ctNA (Circulating tumor Nucleic Acids)
  • Exosomes

By Sample Type:

  • Blood Liquid Biopsy
  • Urine Liquid Biopsy
  • Other (Plasma, Saliva, CSF) Liquid Biopsy

By Application Type:

  • Liquid Biopsy for Lung Cancer
  • Liquid Biopsy for Gastrointestinal Cancer
  • Liquid Biopsy for Prostate Cancer
  • Liquid Biopsy for Breast Cancer
  • Liquid Biopsy for Colorectal Cancer
  • Liquid Biopsy for Leukemia

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific Excluding Japan
  • Japan
  • Middle East and Africa

Frequently Asked Questions

How Big is the Liquid Biopsy Market?

The liquid biopsy market to be worth US$ 1,538.3 million in 2023.

What is the Growth Potential of Liquid biopsy?

The market is expected to expand at a CAGR of 21.7% through 2033.

What is the Future of the Liquid Biopsy Market?

The market is anticipated to account for US$ 10,938.6 million by 2033.

Which Country Offers High Growth Prospects for Liquid Biopsy?

China, with a robust CAGR of 29.7%, is expected to provide high growth opportunities.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Marker Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Marker Type, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Marker Type, 2023 to 2033

        5.3.1. CTCs (Circulating Tumour Cells)

        5.3.2. ctNA (Circulating tumor Nucleic Acids)

        5.3.3. Exosomes

    5.4. Y-o-Y Growth Trend Analysis By Marker Type, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By Marker Type, 2023 to 2033

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Sample Type

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By Sample Type, 2018 to 2022

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Sample Type, 2023 to 2033

        6.3.1. Blood

        6.3.2. Urine

        6.3.3. Others

    6.4. Y-o-Y Growth Trend Analysis By Sample Type, 2018 to 2022

    6.5. Absolute $ Opportunity Analysis By Sample Type, 2023 to 2033

7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application Type

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) Analysis By Application Type , 2018 to 2022

    7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application Type , 2023 to 2033

        7.3.1. Lung Cancer

        7.3.2. Gastrointestinal Cancer

        7.3.3. Prostate Cancer

        7.3.4. Breast Cancer

        7.3.5. Colorectal Cancer

        7.3.6. Leukemia

    7.4. Y-o-Y Growth Trend Analysis By Application Type , 2018 to 2022

    7.5. Absolute $ Opportunity Analysis By Application Type , 2023 to 2033

8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022

    8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Western Europe

        8.3.4. Eastern Europe

        8.3.5. South Asia and Pacific

        8.3.6. East Asia

        8.3.7. Middle East and Africa

    8.4. Market Attractiveness Analysis By Region

9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        9.2.1. By Country

            9.2.1.1. USA

            9.2.1.2. Canada

        9.2.2. By Marker Type

        9.2.3. By Sample Type

        9.2.4. By Application Type

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Marker Type

        9.3.3. By Sample Type

        9.3.4. By Application Type

    9.4. Key Takeaways

10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. Brazil

            10.2.1.2. Mexico

            10.2.1.3. Rest of Latin America

        10.2.2. By Marker Type

        10.2.3. By Sample Type

        10.2.4. By Application Type

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Marker Type

        10.3.3. By Sample Type

        10.3.4. By Application Type

    10.4. Key Takeaways

11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Germany

            11.2.1.2. UK

            11.2.1.3. France

            11.2.1.4. Spain

            11.2.1.5. Italy

            11.2.1.6. Rest of Western Europe

        11.2.2. By Marker Type

        11.2.3. By Sample Type

        11.2.4. By Application Type

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Marker Type

        11.3.3. By Sample Type

        11.3.4. By Application Type

    11.4. Key Takeaways

12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. Poland

            12.2.1.2. Russia

            12.2.1.3. Czech Republic

            12.2.1.4. Romania

            12.2.1.5. Rest of Eastern Europe

        12.2.2. By Marker Type

        12.2.3. By Sample Type

        12.2.4. By Application Type

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Marker Type

        12.3.3. By Sample Type

        12.3.4. By Application Type

    12.4. Key Takeaways

13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. India

            13.2.1.2. Bangladesh

            13.2.1.3. Australia

            13.2.1.4. New Zealand

            13.2.1.5. Rest of South Asia and Pacific

        13.2.2. By Marker Type

        13.2.3. By Sample Type

        13.2.4. By Application Type

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Marker Type

        13.3.3. By Sample Type

        13.3.4. By Application Type

    13.4. Key Takeaways

14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. China

            14.2.1.2. Japan

            14.2.1.3. South Korea

        14.2.2. By Marker Type

        14.2.3. By Sample Type

        14.2.4. By Application Type

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Marker Type

        14.3.3. By Sample Type

        14.3.4. By Application Type

    14.4. Key Takeaways

15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        15.2.1. By Country

            15.2.1.1. GCC Countries

            15.2.1.2. South Africa

            15.2.1.3. Israel

            15.2.1.4. Rest of MEA

        15.2.2. By Marker Type

        15.2.3. By Sample Type

        15.2.4. By Application Type

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Marker Type

        15.3.3. By Sample Type

        15.3.4. By Application Type

    15.4. Key Takeaways

16. Key Countries Market Analysis

    16.1. USA

        16.1.1. Pricing Analysis

        16.1.2. Market Share Analysis, 2022

            16.1.2.1. By Marker Type

            16.1.2.2. By Sample Type

            16.1.2.3. By Application Type

    16.2. Canada

        16.2.1. Pricing Analysis

        16.2.2. Market Share Analysis, 2022

            16.2.2.1. By Marker Type

            16.2.2.2. By Sample Type

            16.2.2.3. By Application Type

    16.3. Brazil

        16.3.1. Pricing Analysis

        16.3.2. Market Share Analysis, 2022

            16.3.2.1. By Marker Type

            16.3.2.2. By Sample Type

            16.3.2.3. By Application Type

    16.4. Mexico

        16.4.1. Pricing Analysis

        16.4.2. Market Share Analysis, 2022

            16.4.2.1. By Marker Type

            16.4.2.2. By Sample Type

            16.4.2.3. By Application Type

    16.5. Germany

        16.5.1. Pricing Analysis

        16.5.2. Market Share Analysis, 2022

            16.5.2.1. By Marker Type

            16.5.2.2. By Sample Type

            16.5.2.3. By Application Type

    16.6. UK

        16.6.1. Pricing Analysis

        16.6.2. Market Share Analysis, 2022

            16.6.2.1. By Marker Type

            16.6.2.2. By Sample Type

            16.6.2.3. By Application Type

    16.7. France

        16.7.1. Pricing Analysis

        16.7.2. Market Share Analysis, 2022

            16.7.2.1. By Marker Type

            16.7.2.2. By Sample Type

            16.7.2.3. By Application Type

    16.8. Spain

        16.8.1. Pricing Analysis

        16.8.2. Market Share Analysis, 2022

            16.8.2.1. By Marker Type

            16.8.2.2. By Sample Type

            16.8.2.3. By Application Type

    16.9. Italy

        16.9.1. Pricing Analysis

        16.9.2. Market Share Analysis, 2022

            16.9.2.1. By Marker Type

            16.9.2.2. By Sample Type

            16.9.2.3. By Application Type

    16.10. Poland

        16.10.1. Pricing Analysis

        16.10.2. Market Share Analysis, 2022

            16.10.2.1. By Marker Type

            16.10.2.2. By Sample Type

            16.10.2.3. By Application Type

    16.11. Russia

        16.11.1. Pricing Analysis

        16.11.2. Market Share Analysis, 2022

            16.11.2.1. By Marker Type

            16.11.2.2. By Sample Type

            16.11.2.3. By Application Type

    16.12. Czech Republic

        16.12.1. Pricing Analysis

        16.12.2. Market Share Analysis, 2022

            16.12.2.1. By Marker Type

            16.12.2.2. By Sample Type

            16.12.2.3. By Application Type

    16.13. Romania

        16.13.1. Pricing Analysis

        16.13.2. Market Share Analysis, 2022

            16.13.2.1. By Marker Type

            16.13.2.2. By Sample Type

            16.13.2.3. By Application Type

    16.14. India

        16.14.1. Pricing Analysis

        16.14.2. Market Share Analysis, 2022

            16.14.2.1. By Marker Type

            16.14.2.2. By Sample Type

            16.14.2.3. By Application Type

    16.15. Bangladesh

        16.15.1. Pricing Analysis

        16.15.2. Market Share Analysis, 2022

            16.15.2.1. By Marker Type

            16.15.2.2. By Sample Type

            16.15.2.3. By Application Type

    16.16. Australia

        16.16.1. Pricing Analysis

        16.16.2. Market Share Analysis, 2022

            16.16.2.1. By Marker Type

            16.16.2.2. By Sample Type

            16.16.2.3. By Application Type

    16.17. New Zealand

        16.17.1. Pricing Analysis

        16.17.2. Market Share Analysis, 2022

            16.17.2.1. By Marker Type

            16.17.2.2. By Sample Type

            16.17.2.3. By Application Type

    16.18. China

        16.18.1. Pricing Analysis

        16.18.2. Market Share Analysis, 2022

            16.18.2.1. By Marker Type

            16.18.2.2. By Sample Type

            16.18.2.3. By Application Type

    16.19. Japan

        16.19.1. Pricing Analysis

        16.19.2. Market Share Analysis, 2022

            16.19.2.1. By Marker Type

            16.19.2.2. By Sample Type

            16.19.2.3. By Application Type

    16.20. South Korea

        16.20.1. Pricing Analysis

        16.20.2. Market Share Analysis, 2022

            16.20.2.1. By Marker Type

            16.20.2.2. By Sample Type

            16.20.2.3. By Application Type

    16.21. GCC Countries

        16.21.1. Pricing Analysis

        16.21.2. Market Share Analysis, 2022

            16.21.2.1. By Marker Type

            16.21.2.2. By Sample Type

            16.21.2.3. By Application Type

    16.22. South Africa

        16.22.1. Pricing Analysis

        16.22.2. Market Share Analysis, 2022

            16.22.2.1. By Marker Type

            16.22.2.2. By Sample Type

            16.22.2.3. By Application Type

    16.23. Israel

        16.23.1. Pricing Analysis

        16.23.2. Market Share Analysis, 2022

            16.23.2.1. By Marker Type

            16.23.2.2. By Sample Type

            16.23.2.3. By Application Type

17. Market Structure Analysis

    17.1. Competition Dashboard

    17.2. Competition Benchmarking

    17.3. Market Share Analysis of Top Players

        17.3.1. By Regional

        17.3.2. By Marker Type

        17.3.3. By Sample Type

        17.3.4. By Application Type

18. Competition Analysis

    18.1. Competition Deep Dive

        18.1.1. BIOCEPT, INC.

            18.1.1.1. Overview

            18.1.1.2. Product Portfolio

            18.1.1.3. Profitability by Market Segments

            18.1.1.4. Sales Footprint

            18.1.1.5. Strategy Overview

                18.1.1.5.1. Marketing Strategy

        18.1.2. Qiagen N.V.

            18.1.2.1. Overview

            18.1.2.2. Product Portfolio

            18.1.2.3. Profitability by Market Segments

            18.1.2.4. Sales Footprint

            18.1.2.5. Strategy Overview

                18.1.2.5.1. Marketing Strategy

        18.1.3. Trovagene, Inc

            18.1.3.1. Overview

            18.1.3.2. Product Portfolio

            18.1.3.3. Profitability by Market Segments

            18.1.3.4. Sales Footprint

            18.1.3.5. Strategy Overview

                18.1.3.5.1. Marketing Strategy

        18.1.4. Janssen Global Services, LLC

            18.1.4.1. Overview

            18.1.4.2. Product Portfolio

            18.1.4.3. Profitability by Market Segments

            18.1.4.4. Sales Footprint

            18.1.4.5. Strategy Overview

                18.1.4.5.1. Marketing Strategy

        18.1.5. MDxHealth SA

            18.1.5.1. Overview

            18.1.5.2. Product Portfolio

            18.1.5.3. Profitability by Market Segments

            18.1.5.4. Sales Footprint

            18.1.5.5. Strategy Overview

                18.1.5.5.1. Marketing Strategy

        18.1.6. Natera, Inc

            18.1.6.1. Overview

            18.1.6.2. Product Portfolio

            18.1.6.3. Profitability by Market Segments

            18.1.6.4. Sales Footprint

            18.1.6.5. Strategy Overview

                18.1.6.5.1. Marketing Strategy

        18.1.7. F. Hoffmann-La Roche Ltd

            18.1.7.1. Overview

            18.1.7.2. Product Portfolio

            18.1.7.3. Profitability by Market Segments

            18.1.7.4. Sales Footprint

            18.1.7.5. Strategy Overview

                18.1.7.5.1. Marketing Strategy

        18.1.8. Silicon Biosystems

            18.1.8.1. Overview

            18.1.8.2. Product Portfolio

            18.1.8.3. Profitability by Market Segments

            18.1.8.4. Sales Footprint

            18.1.8.5. Strategy Overview

                18.1.8.5.1. Marketing Strategy

        18.1.9. Pathway Genomics Corporation

            18.1.9.1. Overview

            18.1.9.2. Product Portfolio

            18.1.9.3. Profitability by Market Segments

            18.1.9.4. Sales Footprint

            18.1.9.5. Strategy Overview

                18.1.9.5.1. Marketing Strategy

        18.1.10. Sysmex Corporation

            18.1.10.1. Overview

            18.1.10.2. Product Portfolio

            18.1.10.3. Profitability by Market Segments

            18.1.10.4. Sales Footprint

            18.1.10.5. Strategy Overview

                18.1.10.5.1. Marketing Strategy

19. Assumptions & Acronyms Used

20. Research Methodology

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

List of Tables

Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2023

Table 2: Global Market Value (US$ Million) Forecast by Marker Type, 2018 to 2023

Table 3: Global Market Value (US$ Million) Forecast by Sample Type, 2018 to 2023

Table 4: Global Market Value (US$ Million) Forecast by Application Type , 2018 to 2023

Table 5: North America Market Value (US$ Million) Forecast by Country, 2018 to 2023

Table 6: North America Market Value (US$ Million) Forecast by Marker Type, 2018 to 2023

Table 7: North America Market Value (US$ Million) Forecast by Sample Type, 2018 to 2023

Table 8: North America Market Value (US$ Million) Forecast by Application Type , 2018 to 2023

Table 9: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2023

Table 10: Latin America Market Value (US$ Million) Forecast by Marker Type, 2018 to 2023

Table 11: Latin America Market Value (US$ Million) Forecast by Sample Type, 2018 to 2023

Table 12: Latin America Market Value (US$ Million) Forecast by Application Type , 2018 to 2023

Table 13: Western Europe Market Value (US$ Million) Forecast by Country, 2018 to 2023

Table 14: Western Europe Market Value (US$ Million) Forecast by Marker Type, 2018 to 2023

Table 15: Western Europe Market Value (US$ Million) Forecast by Sample Type, 2018 to 2023

Table 16: Western Europe Market Value (US$ Million) Forecast by Application Type , 2018 to 2023

Table 17: Eastern Europe Market Value (US$ Million) Forecast by Country, 2018 to 2023

Table 18: Eastern Europe Market Value (US$ Million) Forecast by Marker Type, 2018 to 2023

Table 19: Eastern Europe Market Value (US$ Million) Forecast by Sample Type, 2018 to 2023

Table 20: Eastern Europe Market Value (US$ Million) Forecast by Application Type , 2018 to 2023

Table 21: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2018 to 2023

Table 22: South Asia and Pacific Market Value (US$ Million) Forecast by Marker Type, 2018 to 2023

Table 23: South Asia and Pacific Market Value (US$ Million) Forecast by Sample Type, 2018 to 2023

Table 24: South Asia and Pacific Market Value (US$ Million) Forecast by Application Type , 2018 to 2023

Table 25: East Asia Market Value (US$ Million) Forecast by Country, 2018 to 2023

Table 26: East Asia Market Value (US$ Million) Forecast by Marker Type, 2018 to 2023

Table 27: East Asia Market Value (US$ Million) Forecast by Sample Type, 2018 to 2023

Table 28: East Asia Market Value (US$ Million) Forecast by Application Type , 2018 to 2023

Table 29: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2018 to 2023

Table 30: Middle East and Africa Market Value (US$ Million) Forecast by Marker Type, 2018 to 2023

Table 31: Middle East and Africa Market Value (US$ Million) Forecast by Sample Type, 2018 to 2023

Table 32: Middle East and Africa Market Value (US$ Million) Forecast by Application Type , 2018 to 2023
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

List of Charts

Figure 1: Global Market Value (US$ Million) by Marker Type, 2023 to 2033

Figure 2: Global Market Value (US$ Million) by Sample Type, 2023 to 2033

Figure 3: Global Market Value (US$ Million) by Application Type , 2023 to 2033

Figure 4: Global Market Value (US$ Million) by Region, 2023 to 2033

Figure 5: Global Market Value (US$ Million) Analysis by Region, 2018 to 2023

Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033

Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033

Figure 8: Global Market Value (US$ Million) Analysis by Marker Type, 2018 to 2023

Figure 9: Global Market Value Share (%) and BPS Analysis by Marker Type, 2023 to 2033

Figure 10: Global Market Y-o-Y Growth (%) Projections by Marker Type, 2023 to 2033

Figure 11: Global Market Value (US$ Million) Analysis by Sample Type, 2018 to 2023

Figure 12: Global Market Value Share (%) and BPS Analysis by Sample Type, 2023 to 2033

Figure 13: Global Market Y-o-Y Growth (%) Projections by Sample Type, 2023 to 2033

Figure 14: Global Market Value (US$ Million) Analysis by Application Type , 2018 to 2023

Figure 15: Global Market Value Share (%) and BPS Analysis by Application Type , 2023 to 2033

Figure 16: Global Market Y-o-Y Growth (%) Projections by Application Type , 2023 to 2033

Figure 17: Global Market Attractiveness by Marker Type, 2023 to 2033

Figure 18: Global Market Attractiveness by Sample Type, 2023 to 2033

Figure 19: Global Market Attractiveness by Application Type , 2023 to 2033

Figure 20: Global Market Attractiveness by Region, 2023 to 2033

Figure 21: North America Market Value (US$ Million) by Marker Type, 2023 to 2033

Figure 22: North America Market Value (US$ Million) by Sample Type, 2023 to 2033

Figure 23: North America Market Value (US$ Million) by Application Type , 2023 to 2033

Figure 24: North America Market Value (US$ Million) by Country, 2023 to 2033

Figure 25: North America Market Value (US$ Million) Analysis by Country, 2018 to 2023

Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 28: North America Market Value (US$ Million) Analysis by Marker Type, 2018 to 2023

Figure 29: North America Market Value Share (%) and BPS Analysis by Marker Type, 2023 to 2033

Figure 30: North America Market Y-o-Y Growth (%) Projections by Marker Type, 2023 to 2033

Figure 31: North America Market Value (US$ Million) Analysis by Sample Type, 2018 to 2023

Figure 32: North America Market Value Share (%) and BPS Analysis by Sample Type, 2023 to 2033

Figure 33: North America Market Y-o-Y Growth (%) Projections by Sample Type, 2023 to 2033

Figure 34: North America Market Value (US$ Million) Analysis by Application Type , 2018 to 2023

Figure 35: North America Market Value Share (%) and BPS Analysis by Application Type , 2023 to 2033

Figure 36: North America Market Y-o-Y Growth (%) Projections by Application Type , 2023 to 2033

Figure 37: North America Market Attractiveness by Marker Type, 2023 to 2033

Figure 38: North America Market Attractiveness by Sample Type, 2023 to 2033

Figure 39: North America Market Attractiveness by Application Type , 2023 to 2033

Figure 40: North America Market Attractiveness by Country, 2023 to 2033

Figure 41: Latin America Market Value (US$ Million) by Marker Type, 2023 to 2033

Figure 42: Latin America Market Value (US$ Million) by Sample Type, 2023 to 2033

Figure 43: Latin America Market Value (US$ Million) by Application Type , 2023 to 2033

Figure 44: Latin America Market Value (US$ Million) by Country, 2023 to 2033

Figure 45: Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2023

Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 48: Latin America Market Value (US$ Million) Analysis by Marker Type, 2018 to 2023

Figure 49: Latin America Market Value Share (%) and BPS Analysis by Marker Type, 2023 to 2033

Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Marker Type, 2023 to 2033

Figure 51: Latin America Market Value (US$ Million) Analysis by Sample Type, 2018 to 2023

Figure 52: Latin America Market Value Share (%) and BPS Analysis by Sample Type, 2023 to 2033

Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Sample Type, 2023 to 2033

Figure 54: Latin America Market Value (US$ Million) Analysis by Application Type , 2018 to 2023

Figure 55: Latin America Market Value Share (%) and BPS Analysis by Application Type , 2023 to 2033

Figure 56: Latin America Market Y-o-Y Growth (%) Projections by Application Type , 2023 to 2033

Figure 57: Latin America Market Attractiveness by Marker Type, 2023 to 2033

Figure 58: Latin America Market Attractiveness by Sample Type, 2023 to 2033

Figure 59: Latin America Market Attractiveness by Application Type , 2023 to 2033

Figure 60: Latin America Market Attractiveness by Country, 2023 to 2033

Figure 61: Western Europe Market Value (US$ Million) by Marker Type, 2023 to 2033

Figure 62: Western Europe Market Value (US$ Million) by Sample Type, 2023 to 2033

Figure 63: Western Europe Market Value (US$ Million) by Application Type , 2023 to 2033

Figure 64: Western Europe Market Value (US$ Million) by Country, 2023 to 2033

Figure 65: Western Europe Market Value (US$ Million) Analysis by Country, 2018 to 2023

Figure 66: Western Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 67: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 68: Western Europe Market Value (US$ Million) Analysis by Marker Type, 2018 to 2023

Figure 69: Western Europe Market Value Share (%) and BPS Analysis by Marker Type, 2023 to 2033

Figure 70: Western Europe Market Y-o-Y Growth (%) Projections by Marker Type, 2023 to 2033

Figure 71: Western Europe Market Value (US$ Million) Analysis by Sample Type, 2018 to 2023

Figure 72: Western Europe Market Value Share (%) and BPS Analysis by Sample Type, 2023 to 2033

Figure 73: Western Europe Market Y-o-Y Growth (%) Projections by Sample Type, 2023 to 2033

Figure 74: Western Europe Market Value (US$ Million) Analysis by Application Type , 2018 to 2023

Figure 75: Western Europe Market Value Share (%) and BPS Analysis by Application Type , 2023 to 2033

Figure 76: Western Europe Market Y-o-Y Growth (%) Projections by Application Type , 2023 to 2033

Figure 77: Western Europe Market Attractiveness by Marker Type, 2023 to 2033

Figure 78: Western Europe Market Attractiveness by Sample Type, 2023 to 2033

Figure 79: Western Europe Market Attractiveness by Application Type , 2023 to 2033

Figure 80: Western Europe Market Attractiveness by Country, 2023 to 2033

Figure 81: Eastern Europe Market Value (US$ Million) by Marker Type, 2023 to 2033

Figure 82: Eastern Europe Market Value (US$ Million) by Sample Type, 2023 to 2033

Figure 83: Eastern Europe Market Value (US$ Million) by Application Type , 2023 to 2033

Figure 84: Eastern Europe Market Value (US$ Million) by Country, 2023 to 2033

Figure 85: Eastern Europe Market Value (US$ Million) Analysis by Country, 2018 to 2023

Figure 86: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 87: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 88: Eastern Europe Market Value (US$ Million) Analysis by Marker Type, 2018 to 2023

Figure 89: Eastern Europe Market Value Share (%) and BPS Analysis by Marker Type, 2023 to 2033

Figure 90: Eastern Europe Market Y-o-Y Growth (%) Projections by Marker Type, 2023 to 2033

Figure 91: Eastern Europe Market Value (US$ Million) Analysis by Sample Type, 2018 to 2023

Figure 92: Eastern Europe Market Value Share (%) and BPS Analysis by Sample Type, 2023 to 2033

Figure 93: Eastern Europe Market Y-o-Y Growth (%) Projections by Sample Type, 2023 to 2033

Figure 94: Eastern Europe Market Value (US$ Million) Analysis by Application Type , 2018 to 2023

Figure 95: Eastern Europe Market Value Share (%) and BPS Analysis by Application Type , 2023 to 2033

Figure 96: Eastern Europe Market Y-o-Y Growth (%) Projections by Application Type , 2023 to 2033

Figure 97: Eastern Europe Market Attractiveness by Marker Type, 2023 to 2033

Figure 98: Eastern Europe Market Attractiveness by Sample Type, 2023 to 2033

Figure 99: Eastern Europe Market Attractiveness by Application Type , 2023 to 2033

Figure 100: Eastern Europe Market Attractiveness by Country, 2023 to 2033

Figure 101: South Asia and Pacific Market Value (US$ Million) by Marker Type, 2023 to 2033

Figure 102: South Asia and Pacific Market Value (US$ Million) by Sample Type, 2023 to 2033

Figure 103: South Asia and Pacific Market Value (US$ Million) by Application Type , 2023 to 2033

Figure 104: South Asia and Pacific Market Value (US$ Million) by Country, 2023 to 2033

Figure 105: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2018 to 2023

Figure 106: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 107: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 108: South Asia and Pacific Market Value (US$ Million) Analysis by Marker Type, 2018 to 2023

Figure 109: South Asia and Pacific Market Value Share (%) and BPS Analysis by Marker Type, 2023 to 2033

Figure 110: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Marker Type, 2023 to 2033

Figure 111: South Asia and Pacific Market Value (US$ Million) Analysis by Sample Type, 2018 to 2023

Figure 112: South Asia and Pacific Market Value Share (%) and BPS Analysis by Sample Type, 2023 to 2033

Figure 113: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Sample Type, 2023 to 2033

Figure 114: South Asia and Pacific Market Value (US$ Million) Analysis by Application Type , 2018 to 2023

Figure 115: South Asia and Pacific Market Value Share (%) and BPS Analysis by Application Type , 2023 to 2033

Figure 116: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Application Type , 2023 to 2033

Figure 117: South Asia and Pacific Market Attractiveness by Marker Type, 2023 to 2033

Figure 118: South Asia and Pacific Market Attractiveness by Sample Type, 2023 to 2033

Figure 119: South Asia and Pacific Market Attractiveness by Application Type , 2023 to 2033

Figure 120: South Asia and Pacific Market Attractiveness by Country, 2023 to 2033

Figure 121: East Asia Market Value (US$ Million) by Marker Type, 2023 to 2033

Figure 122: East Asia Market Value (US$ Million) by Sample Type, 2023 to 2033

Figure 123: East Asia Market Value (US$ Million) by Application Type , 2023 to 2033

Figure 124: East Asia Market Value (US$ Million) by Country, 2023 to 2033

Figure 125: East Asia Market Value (US$ Million) Analysis by Country, 2018 to 2023

Figure 126: East Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 127: East Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 128: East Asia Market Value (US$ Million) Analysis by Marker Type, 2018 to 2023

Figure 129: East Asia Market Value Share (%) and BPS Analysis by Marker Type, 2023 to 2033

Figure 130: East Asia Market Y-o-Y Growth (%) Projections by Marker Type, 2023 to 2033

Figure 131: East Asia Market Value (US$ Million) Analysis by Sample Type, 2018 to 2023

Figure 132: East Asia Market Value Share (%) and BPS Analysis by Sample Type, 2023 to 2033

Figure 133: East Asia Market Y-o-Y Growth (%) Projections by Sample Type, 2023 to 2033

Figure 134: East Asia Market Value (US$ Million) Analysis by Application Type , 2018 to 2023

Figure 135: East Asia Market Value Share (%) and BPS Analysis by Application Type , 2023 to 2033

Figure 136: East Asia Market Y-o-Y Growth (%) Projections by Application Type , 2023 to 2033

Figure 137: East Asia Market Attractiveness by Marker Type, 2023 to 2033

Figure 138: East Asia Market Attractiveness by Sample Type, 2023 to 2033

Figure 139: East Asia Market Attractiveness by Application Type , 2023 to 2033

Figure 140: East Asia Market Attractiveness by Country, 2023 to 2033

Figure 141: Middle East and Africa Market Value (US$ Million) by Marker Type, 2023 to 2033

Figure 142: Middle East and Africa Market Value (US$ Million) by Sample Type, 2023 to 2033

Figure 143: Middle East and Africa Market Value (US$ Million) by Application Type , 2023 to 2033

Figure 144: Middle East and Africa Market Value (US$ Million) by Country, 2023 to 2033

Figure 145: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2018 to 2023

Figure 146: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 147: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 148: Middle East and Africa Market Value (US$ Million) Analysis by Marker Type, 2018 to 2023

Figure 149: Middle East and Africa Market Value Share (%) and BPS Analysis by Marker Type, 2023 to 2033

Figure 150: Middle East and Africa Market Y-o-Y Growth (%) Projections by Marker Type, 2023 to 2033

Figure 151: Middle East and Africa Market Value (US$ Million) Analysis by Sample Type, 2018 to 2023

Figure 152: Middle East and Africa Market Value Share (%) and BPS Analysis by Sample Type, 2023 to 2033

Figure 153: Middle East and Africa Market Y-o-Y Growth (%) Projections by Sample Type, 2023 to 2033

Figure 154: Middle East and Africa Market Value (US$ Million) Analysis by Application Type , 2018 to 2023

Figure 155: Middle East and Africa Market Value Share (%) and BPS Analysis by Application Type , 2023 to 2033

Figure 156: Middle East and Africa Market Y-o-Y Growth (%) Projections by Application Type , 2023 to 2033

Figure 157: Middle East and Africa Market Attractiveness by Marker Type, 2023 to 2033

Figure 158: Middle East and Africa Market Attractiveness by Sample Type, 2023 to 2033

Figure 159: Middle East and Africa Market Attractiveness by Application Type , 2023 to 2033

Figure 160: Middle East and Africa Market Attractiveness by Country, 2023 to 2033

Recommendations

Healthcare

Aspiration & Biopsy Needles Market

Published : April 2023

Healthcare

Injection Pen Market

Published : February 2023

Explore Healthcare Insights

View Reports